A single medication that addresses the reward dysregulation underlying both could simplify treatment, improve compliance (patients are motivated by visible weight loss), and reduce the sense of being pulled in multiple directions that so many patients describe
[11] Tirzepatide (Mounjaro) has received a positive NICE recommendation in the UK, but this is specifically for the treatment of type 2 diabetes, not for weight management
By promoting a balanced gut microbiome, postbiotics can enhance digestive health, which is essential for optimal metabolic function and weight management
Their blue cap has a drying agent to protect the medication from moisture
Incretin therapies: highlighting common features and differences in the modes of action of glucagonlike peptide1 receptor agonists and dipeptidyl peptidase4 inhibitors
Our experienced healthcare providers will partner with you to determine if GLP-1-based therapies can help you achieve your health goals